Months of cold outreach
Traditional biopharma raises stay stuck in linear pipelines—slow, cold, and inefficient for 6–12+ months.
Post an opportunity. AI intelligently routes it to the right investors. Micro-commitments and warm intros spread exponentially through trusted networks.
Illustrative metrics. Actual routing adapts to modality, stage, geography, and verified trust edges inside your syndicate graph.
The problem
Traditional biopharma raises stay stuck in linear pipelines—slow, cold, and inefficient for 6–12+ months.
The best intros depend on a handful of brokers. One missed hop and momentum dies before science gets a fair hearing.
Capital and conviction already exist across your extended graph—they’re just never activated in parallel.
The solution
Visual flow: Post → AI Smart Match → Micro-commitment or intro → viral propagation → accelerated close.
Structured opportunity with modality, stage, and thesis hooks.
Models investor fit using stage, mandate fit, and graph probability.
Small commitments and curated intros seed trusted propagation.
Warm edges amplify until the right syndicate crystallizes—fast.
Ripple dashboard keeps signal high and diligence coordinated.
Why BioSyndex
We combine graph-aware AI with operator-grade compliance so every signal stays sharp, warm, and executable.
Grounded in hundreds of verified companies and investors—not generic CRM plumbing.
Modalities, stages, catalysts, and network probability inform every routing decision.
Structured flows that respect accredited pathways and syndication guardrails.
Features
Matches opportunities to the highest-likelihood investors using multimodal deal signals.
One commitment triggers exponential warm propagation across trusted edges.
Watch capital commitments and intros compose live as your syndicate activates.
Structured attestations keep diligence crisp for sophisticated counterparties.
Transparent momentum markers align incentives across companies and investors.
Advanced graph tooling for frequent syndicate leads and institutional desks.
Deal spotlight
Confidence blends mandate fit, timing, warm-path depth, and verification coverage—shown here as illustrative scores.
AtlasGene · Phase II oncology
Series B
Warm-path depth strong · mandate overlap high · catalyst timing aligned with IC windows.
Northwind Bio · ADC platform
Seed extension
Warm-path depth strong · mandate overlap high · catalyst timing aligned with IC windows.
HelioLattice · radiopharma
Crossover
Warm-path depth strong · mandate overlap high · catalyst timing aligned with IC windows.
Traction
Backed by a proprietary network of 200+ biopharma companies and investors ready for Day 1.
Curated for modality diversity, institutional discipline, and disciplined syndicate hygiene—not spray-and-pray lists.
How it works
Stage-aware prompts capture scientific differentiation, financing goals, and syndicate preferences.
Models rank edges by probability of relevance, responsiveness, and strategic fit.
Small checks and intros ladder into broader conviction without boiling the ocean.
Live telemetry keeps teams aligned from first ping to term sheet discipline.
Product demo
Placeholder embed—swap in your Loom, Wistia, or Vimeo production URL when ready.
Demo video embed
Drop an iframe or hosted player here—aspect ratio locked to 16:9 for Lighthouse-friendly layout.